Filing Details

Accession Number:
0001179110-17-011728
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-08-22 17:37:00
Reporting Period:
2017-08-20
Accepted Time:
2017-08-22 16:37:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1080014 Innoviva Inc. INVA Pharmaceutical Preparations (2834) 943265960
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1622268 Eric Desparbes 2000 Sierra Point Parkway
Suite 500
Brisbane CA 94005
Svp And Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-08-20 5,770 $12.28 344,993 No 4 F Direct
Common Stock Disposition 2017-08-21 1,825 $12.20 343,168 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 F Direct
No 4 S Direct
Footnotes
  1. The shares were withheld by the Company to satisfy income tax withholding obligations associated with the quarterly vesting of previously granted employee equity awards.
  2. This sale was effected for tax planning purposes pursuant to the Reporting Person's Rule 10b5-1 Trading Plan dated December 15, 2016.